HC Wainwright & Co. Reiterates Neutral on Zymeworks, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Robert Burns has reiterated a Neutral rating on Zymeworks (NASDAQ:ZYME) and maintained a $10 price target.
June 06, 2024 | 10:17 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
HC Wainwright & Co. analyst Robert Burns has reiterated a Neutral rating on Zymeworks and maintained a $10 price target. This suggests that the analyst does not foresee significant short-term movement in the stock price.
The reiteration of a Neutral rating and maintenance of the $10 price target by HC Wainwright & Co. indicates that the analyst does not expect significant short-term changes in Zymeworks' stock price. This suggests a stable outlook for the company in the near term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100